title: [Local immune tolerance mechanisms in kidney cancer].
abstract: Many arguments suggest that renal tumours are immunogenic. However, the immune cells present around or within the tumour are unable to induce tumour rejection and the results of immunotherapy in metastatic renal cancer remain disappointing regardless of the protocols used. The objective of this study was to review the main mechanisms by which a renal tumour can escape immune destruction. These mechanisms can concern: tumour antigens, antigen-presenting molecules on the cell surface or defects of the cell machinery leading to the preparation of these molecules. Defects may also concern intercellular communications, especially adhesion and co-stimulation molecules. The immune cells present may also be defective, presenting qualitative or quantitative deficits, abnormalities of the T receptor, defect of cytokine production and these defects may concern both effector cells and antigen-presenting cells. The capacity of tumour cells to release anergic substances, i.e. substances which paralyze the immune system, also constitutes another very powerful immunosuppressive mechanism. These substances are cytokines, especially TGF-b. This anergy can also be mediated by intercellular contacts between tumour cells and lymphocytes, especially via the Fas system. It is important to study these mechanisms for several reasons: 1/Understanding of anergy mechanisms in order to discover new therapeutic targets or to short-circuit these mechanisms in vitro; 2/Definition of an "immune phenotype" of the tumour which should be evaluated as a prognostic marker both for survival after radical surgery of localized tumours as a prognostic factor for response to immunotherapy in metastatic forms.
authors.affiliation: Service d'Urologie, CHU Pontchaillou, Rennes, France. jean-jacques.patard@chu-rennes.fr
authors.forename: Jean-Jacques
authors.initials: JJ
authors.lastname: Patard
authors.forename: Françoise
authors.initials: F
authors.lastname: Bouet
authors.forename: Nathalie
authors.initials: N
authors.lastname: Rioux-Leclercq
authors.forename: Bernard
authors.initials: B
authors.lastname: Lobel
authors.forename: Véronique
authors.initials: V
authors.lastname: Catros-Quemener
authors.forename: François
authors.initials: F
authors.lastname: Guillé
mesh_terms: D017951:Antigen Presentation / Q000276:immunology; D016207:Cytokines / Q000276:immunology; D006801:Humans; D007108:Immune Tolerance; D007680:Kidney Neoplasms / Q000276:immunology*
chemical_list: D016207:Cytokines